Lambrotin

Composition

Each uncoated tablet contains:

• Ambroxol Hydrochloride BP 30 mg;
• Cetirizine Hydrochloride BP 5 mg.
• Pharmacotherapeutic group: Mucolytics and antihistaminic drug.

Indications for use

Respiratory tract diseases with discharge of viscous mucus:

• Bronchial asthma with difficulty sputum discharge;
•  Acute and chronic bronchitis;
•  Pneumonia;
•  Bronchoectatic disease;
•  Chronic obstructive pulmonary disease.

Mode of application

Oral use, with meals and drinking a small amount of liquid.
Adults and adolescents over 12 years: 1 tablet 2 times a day.
Children aged 6 to 12 years: ½ tablet 2 times a day.
Not recommended for use without a doctor’s prescription for more than 4-5 days.
During treatment, need to drink plenty of fluids (juice, tea, water), as it increases the mucolytic effect of the drug.